Bioterrorism and IVDA BSIs Flashcards

1
Q

Events that involve a biological agent/ disease and result in mass casualties, such as a bioterrorism attach, a pandemic, or an outbreak of an emerging infectious disease

A

Infectious disease disasters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why are infectious disease disasters different from other types of disasters?

A

Increase risk of communicable disease spread during and after the incident

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Principles of emergency management

A
  • mitigation
  • preparedness
  • response
  • Recovery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Characteristics of bioterrorism agents

A

1) ability to be dispersed in aerosols (1-5 microns)

2) Ability to deliver aerosols with simple technology

3) feasibility of agents to infect large numbers of the population if delivered upwind

4) ability to spread infection, disease, panic, and fear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Most likely release of bioterrorist agent

A

Aerosol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Methods of dissemination biological agents

A
  • Aerosol
  • oral
  • percutaneous
  • infected animal vector
  • human to human
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

the intentional use of a biological agent or derivative of such an agent to inflect harm or death onto a civilian population

A

Bioterrorism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Intentional use of biological agent that targets military personnel

A

Biological warfare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Is bioterrorism preparedness a requirement?

A

Yes, required by healthcare and public health regulatory agencies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What do healthcare and public health regulating agencies require for bioterrorism preparedness?

A

Comprehensive emergency management progran

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does the potential impact of bioterrorism depend on?

A

1) agent used
2) amount disseminated
3) Dispersal method
4) weather/ release conditions
5) preexisting immunity
6) how quickly attack id’d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Category of agent that poses the highest risk to national security

A

Category A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe category A

A
  • easily disseminated or transmitted from person- person
  • high mortality
  • cause public panic and social disruption
  • require special preparedness actions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Category A agents

A
  • Anthrax
  • Botulism
  • Plague
  • Smallpox
  • Tularemia
  • Viral hemorrhagic fevers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Category: Anthrax

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Category: Botulism

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Category plague

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Category Smallpox

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Category tularemia

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Category viral hemorrhagic fever

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

category of agents that pose the second highest risk to national security

A

Category B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe category B agents

A
  • moderately easy to disseminate
  • low mortality rates
  • require enhancement of diagnostic and surveillance capability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Category B agents

A
  • WNV
  • Caliciviruses
  • Hep A
  • Ricin toxin
  • Salmonella
  • Diarrheagenic E. Coli
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Category WNV

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Category calicivirus

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Category Hep A

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Category Ricin

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Category Salmonella

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Category diarrhea e. coli

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Category of bioterrorism agents that are emerging pathogens that could be engineered for mass dissemination

A

Category C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Describe category C agents

A
  • Available
  • Easily produced and disseminated
  • Potential for high mortality rates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Examples of category C agents

A
  • Influenza
  • SARS
  • Rabies
  • MDR TB
  • Yellow fever
  • Tickborne hemorrhagic fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Category Influenza

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Category SARS

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Category Rabies

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Category MDR TB

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Category Yellow Fever

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Category tickborne hemorrhagic fever

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Pandemic phase 1

A

Low risk of human cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Pandemic phase 2

A

Higher risk of human cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Pandemic phase 3

A

No or very limited human-to human transmission

42
Q

Pandemic phase 4

A

Evidence of increased human-human transmission

43
Q

Pandemic phase 5

A

Evidence of significant human-human transmission

44
Q

Pandemic phase 6

A

Efficient and sustained human- human transmission

45
Q

What phases does the inter-pandemic phase include?

A

phase 1 and 2 (new virus in animals, no human cases)

46
Q

What phases does the pandemic alert include?

A

Phases 3-4- new virus causes human cases

47
Q

What phases does the pandemic include?

A

Phase 5-6 (Significant Human- human transmission)

48
Q

Q fever category

A

b

49
Q

What are the two major sources of intravascular device- associated bloodstream infections?

A

1) colonization of the IV device (catheter associated infection)

2) contamination of the fluid administered through the device (Infusate-associated infection)

50
Q

What is the cause of most epidemic intravascular device associated bloodstream infections?

A

Contaminated infusate

51
Q

What is the cause of most endemic intravascular device associated bloodstream infections?

A

Catheter-associated infections

52
Q

When obtaining blood cultures to guide antimicrobial therapy, what IP practices are important?

A

1) attention to skin disinfection
2) Collection of adequate amount of blood
3) careful handling of specimen

53
Q

Recent studies have shown that consistent application of high-yield preventative ________ can lead to substantial and sustained reductions in facility rates of CLABSIs

A

Bundles

54
Q

What are some examples of novel technologies to prevent CLABSIs?

A

1) Anti-infective catheters
2) Antiseptic dressings
3) antibiotic lock solutions

55
Q

What must happen first for a microorganism to cause a CLABSI?

A

must gain access to the extraluminal or intraluminal surface of the device

56
Q

What happens when a microorganism adheres to a catheter?

A

Produce and become incorporated into a biofilm

57
Q

What are the 3 mechanisms for microorganisms to gain access to the bloodstream?

A

1) skin organisms invade percutaneous tract
2) Microorganisms contaminate the catheter hub
3) organisms carried hematogenously to implanted ivd from remote sources

58
Q

When do CLABSIs with skin organisms occur?

A

at time of insertion or days following

59
Q

When do microorganisms contaminate the catheter hub or lumen?

A

when the catheter is inserted over a percutaneous guidewire or later manipulated

60
Q

prevention measure for skin organisms causing CLABSIs?

A

CHG, skin antisepsis

61
Q

Prevention for microorganisms contaminating the catheter hub

A

scrub the hub

62
Q

How long are short term IVDs in place?

A

<10 days

63
Q

Examples of Short-term IVDs

A

1) peripheral intravenous (IV) catheters
2) Arterial catheters
3) noncuffed, nontunneled CVCs

64
Q

What causes most short-term device associated BSIs?

A

cutaneous microorganisms from insertion site that gain access extraluminally

65
Q

How long are long term IVDs in place?

A

> 10 days

66
Q

Examples of long-term IVDs?

A

1) cuffed Hickman and Broviac type catheters
- subcutaneous central ports
- PICCs

67
Q

Predominant mode of BSI for long-term IVDs

A

contamination of the catheter hub and luminal fluid

68
Q

What are infusates that are administered through IVDs?

A

1) parenteral fluid
2) Blood products
3) IV medications

69
Q

Are contaminated infusates a common cause of endemic infusion-associated infection with most short-term IVDs?

A

No

70
Q

What is the most common bacteria (gram stain and shape) associated with epidemics of infusion associated BSI?

A

Gram-negative bacilli

71
Q

When an infusate is contaminated and the contaminant was introduced during its manufacture

A

Intrinsic contamination

72
Q

When an infusate is contaminated and the contaminant was introduced during it’s preparation and administration in the healthcare setting

A

Extrinsic contamination

73
Q

top 3 pathogens most commonly isolated from intravascular devices?

A

1) Coagulase- negative staph (31%)
2) Staph aureus (18%)
3) Enteric gram-negative bacilli

74
Q

If these species are recovered from multiple cultures, it is strongly suggestive of an IVD infection

A
  • Staph
  • Corynebacterium or bacillus
  • candida
  • malassezia
75
Q

How many blood cultures should be obtained when there is an IVD? where from?

A

2 separate sites

@ least 1 drawn from peripheral vein by percutaneous venipuncture

76
Q

What are strategies to prevent IVDA BSIs?

A

1) Choice of catheter and site of device insertion
2) Barrier precautions
3) Intravenous teams
4) cutaneous antisepsis

77
Q

What is the lowest risk site for IVD insertion to prevent BSIs?

A

Subclavian vein insertion

78
Q

What is the highest risk insertion site for CLABSIs?

A

Femoral vein insertion

79
Q

What insertion sites for CLABSIs pose intermediate risk?

A

Jugular vein insertions

80
Q

How often is it recommended to replace central venous catheters?

A

Only when indicated

  • remove promptly when no longer deemed necessary
  • inspect insertion site daily for signs of infection and change or remove when catheter insertion site infection is suspected
81
Q

What is a central line?

A

Catheter inserted into a large vein close to the heart (Superior vena cava or inferior vena cava)

82
Q

Sites for insertion of central line

A

1) Internal jugular vein, terminates in SVC
2) Subclavian- terminates in SVC
3) Femoral (emergency)- terminates in IVC

83
Q

Where is the subclavian vein

A

Under collar bone

84
Q

Why have a central line for meds

A

Can administer meds that are irritants or vesicants

multiple infusions

85
Q

PICC description

A

Peripherally Inserted Central Catheter

Basilic vein in arm, terminates in SVC
Less prone to infection

86
Q

Describe tunneled lines

A

-inserted through skin
- access vein under skin
-cuff to hold in place
- less risk of infection
- often used for patients going home with device

87
Q

Describe a port

A
  • similar to tunneled
  • Access hub under skin
  • tunneled into vein
  • chemo patients
88
Q

Hemodialysis line description

A
  • Larger lumens, faster flow
  • Temporary
  • red and blue end or pigtail access
89
Q

Two types of central lines

A

General- single, double. triple lumens

-specialty: introducer, sheath, MAC (larger lumen, faster flow)

90
Q

Central line care: line patency

A

Flush line and check blood return (not always able), use push pause manuever

91
Q

Can you draw cultures from the central line?

A

No, peripheral sticks because may have line colonization

92
Q

What to do if suspecting infected central line?

A

Remove or replace line

93
Q

Care for dressing/ site: when to change the dressing

A
  • Border coming up
  • or every 7 days
    If guaze present, change in 24 hours
94
Q

PPE for central line dressing changes

A
  • sterile gloves
  • mask
95
Q

Skin prep for central line dressing changes

A
  • CHG prep
96
Q

What type of dressing to use for central line?

A

Antimicrobial patch that is the correct size (impregnated with CHG)

97
Q

Line Care

A
  • minimize access to tubing and central line
  • Curos caps (sit on top of open port), but still need to scrub for 15 seconds with alcohol or CHG
  • Keep pressure caps to prevent blood backflow
98
Q

How often to change pressure caps

A

Every 72 hours- 96 hours

99
Q

Describe central line insertion

A
  • typically bedside
  • new, clean line
  • sterile procedure
100
Q

PPE for central line insertion

A
  • cap and mask for everyone
  • inserter fully sterile
  • Sterile drape
101
Q

Prep for Central Line insertion

A

CHG prep